Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
IIL to produce drug substance for Covaxin from June
Plans to dispatch the first batch to Bharat Biotech by July
Zydus Cadila gets USFDA approval for Fluphenazine Hydrochloride Tablets
This medication is used to treat symptoms of a certain type of mental/mood condition (schizophrenia)
120 days to make, test and release each Covaxin batch: Bharat Biotech
Production scale-up of vaccines is a step-by-step process, involving several regulatory SOPs of GMP. There is a four-month lag…
Study reveals new DNA vaccine for COVID-19 effective in mice, hamsters
DNA vaccines can often be produced more quickly and at lower cost, and transported without the requirement of cold temperatures,…
IIT Mandi study reveal structure of NSP1 C-terminal region in isolation, a key protein in COVID-19…
This helps in understanding its mode of action, its role in the spread and severity of the disease and the development of…
Neuropathic pain market to reach $25.2 billon by 2027: GlobalData
There are currently 315 pain therapeutics in development globally
SP delivers world’s largest installation of commercial freeze dryers for diagnostics production
With the urgency of the pandemic and requirement for speed, SP was able to complete the delivery of 16 freeze dryers – including…
Astrazeneca gives rights to trademark for three diabetes drug brands to Sun Pharma
Consequently, AstraZeneca India and Sun Pharma have discontinued their existing distribution services agreement signed in 2016,…
Merck launches synthetic cholesterol product to meet high demand for lipids
This neutral lipid, used in commercially marketed products, is more than 99 per cent pure; offers high batch-to-batch consistency…
RDIF, UNICEF sign agreement for supply of 220 million doses of Sputnik V vaccine
Concurrently, RDIF will be holding a separate discussion with Gavi, the Vaccine Alliance to see the Sputnik V vaccine considered…